Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new page revision, v3.6.6, has been posted, replacing the previous v3.6.5. This appears to be a minor site update rather than a modification to study data or participant information.SummaryDifference0.0%

- Check20 days agoChange DetectedThe study record now includes an NIH funding line indicating support from a U.S. NIH grant/contract in 2018, adding funding context to the study documentation. This clarifies the source of support for the trial within the record.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, representing a metadata revision of the study record. No study content or results are altered by this change.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This reflects a new release of the page or its documents, not a change to the trial data or study details.SummaryDifference0.0%

- Check63 days agoChange DetectedA bibliographic entry for a Lancet publication about Spesolimab use in generalised pustular psoriasis flares has been removed from the Publications section. This update does not change the study design, endpoints, or results.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a newer release of the page content.SummaryDifference0.0%

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.